73 / 88
71
LISI 2015
LISI MEDICAL benefited in 2015 from a favorable environment
in all the markets for bone surgery. This sustainable dynamic allowed
the division to maintain a level of organic growth that was in line with
the forecasts. The reorganization of the supply and the improvements
in the operational performance offer solid prospects.
74.8
€M
2015 sales revenue
4.6
€M
of CAPEX
4.1
€M
EBIT
573
staff
+5.2
%
progression
5
%
of the Group’s sales
MEDICAL